» Articles » PMID: 22888252

5-HTP Efficacy and Contraindications

Overview
Publisher Dove Medical Press
Specialty Psychiatry
Date 2012 Aug 14
PMID 22888252
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

L-5-hydroxytryptophan (5-HTP) is the immediate precursor of serotonin. It is readily synthesized into serotonin without biochemical feedback. This nutrient has a large and strong following who advocate exaggerated and inaccurate claims relating to its effectiveness in the treatment of depression and a number of other serotonin-related diseases. These assertions are not supported by the science. Under close examination, 5-HTP may be contraindicated for depression in some of the very patients for whom promoters of 5-HTP advocate its use.

Citing Articles

Beyond the Brain: Perinatal Exposure of Rats to Serotonin Enhancers Induces Long-Term Changes in the Jejunum and Liver.

Gracan R, Blazevic S, Brizic M, Hranilovic D Biomedicines. 2024; 12(2).

PMID: 38397959 PMC: 10887406. DOI: 10.3390/biomedicines12020357.


Metabolic engineering of Escherichia coli for efficient production of L-5-hydroxytryptophan from glucose.

Zhang Z, Yu Z, Wang J, Yu Y, Li L, Sun P Microb Cell Fact. 2022; 21(1):198.

PMID: 36153615 PMC: 9509612. DOI: 10.1186/s12934-022-01920-3.


Effects of Duodenal 5-Hydroxytryptophan Perfusion on Melatonin Synthesis in GI Tract of Sheep.

Pan J, Li F, Wang C, Li X, Zhang S, Zhang W Molecules. 2021; 26(17).

PMID: 34500708 PMC: 8433724. DOI: 10.3390/molecules26175275.


Advances in Nutritional Epigenetics-A Fresh Perspective for an Old Idea. Lessons Learned, Limitations, and Future Directions.

Sedley L Epigenet Insights. 2021; 13:2516865720981924.

PMID: 33415317 PMC: 7750768. DOI: 10.1177/2516865720981924.


Serotonin stimulated parathyroid hormone related protein induction in the mammary epithelia by transglutaminase-dependent serotonylation.

Sheftel C, Hernandez L PLoS One. 2020; 15(10):e0241192.

PMID: 33095824 PMC: 7584195. DOI: 10.1371/journal.pone.0241192.


References
1.
van Hiele L . l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions. Neuropsychobiology. 1980; 6(4):230-40. DOI: 10.1159/000117757. View

2.
Stein A, Hinz M, Uncini T . Amino acid-responsive Crohn's disease: a case study. Clin Exp Gastroenterol. 2011; 3:171-7. PMC: 3108661. DOI: 10.2147/CEG.S15340. View

3.
Charlton C, Crowell Jr B . Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa. Pharmacol Biochem Behav. 1992; 43(2):423-31. DOI: 10.1016/0091-3057(92)90172-c. View

4.
Hinz M, Stein A, Uncini T . The dual-gate lumen model of renal monoamine transport. Neuropsychiatr Dis Treat. 2010; 6:387-92. PMC: 2938287. DOI: 10.2147/ndt.s11704. View

5.
Garcia N, Berndt T, TYCE G, KNOX F . Chronic oral L-DOPA increases dopamine and decreases serotonin excretions. Am J Physiol. 1999; 277(5):R1476-80. DOI: 10.1152/ajpregu.1999.277.5.R1476. View